Gedivumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Gedivumab Usage And Synthesis

Uses

Gedivumab (MHAA4549A; RG7745) is a human monoclonal antibody that targets influenza A virus (IAV) with high specificity and binds to the highly conserved stem region of the IAV haemagglutinin protein, thereby preventing haemagglutinin maturation and blocking haemagglutinin-mediated membrane fusion in the intranucleosome. Gedivumab can be used in IAV infection disease studies[1].

References

[1] Jeremy J Lim, et al. Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5437-44. DOI:10.1128/AAC.00607-16

Gedivumab(1807954-17-1)Related Product Information

• Crovalimab
• Zenocutuzumab
• Atinumab
• Research Grade Acazicolcept (DHC83404)
• Manfidokimab
• Ubamatamab
• Tirnovetmab
• Coltuximab Ravtansine
• Immunoglobulin G4,anti-(human CD4 (antigen)) (human-mouse monoclonal OKTcdr4a complementarydetermining region-grafted g4-chain), disulfide with human-mouse monoclonal OKTcdr4a complementarydetermining region-grafted k-chain, dimer (9CI)
• Roledumab